Newsletter | December 12, 2022

12.12.22 -- Drug Discovery And Screening With RNA-Lipid Nanoparticles

Genomic Medicine Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics

Read this article to learn more about the key stages of drug discovery and screening and how to overcome key bottlenecks in screening mRNA-Lipid Nanoparticles (LNPs) to rapidly develop genomic medicines.

Boost LNP Drug Potency With Optimized Delivery Formulations

Download this ebook to learn more about biomedical applications of LNPs, lipid nanoparticle excipients, formulation optimization and LNP safety.

Key Stages In mRNA-Based Therapeutic Development From Discovery To Commercialization

Each regulatory phase of mRNA therapeutic development consists of specific goals, steps, and end points. Read this article to learn more about the fundamentals of developing mRNA-LNP drug products from discovery through to commercialization.

Strategies To Overcome Delays In The Development Of Genomic Medicines

Read this article to learn how to overcome key issues that arise at the various stages in the development of LNP-based drug products, such as how to choose the appropriate delivery technology, accelerate preclinical programs and clinical drug development, and establish strategic partnerships.

Ultra-Low-Volume Production Of mRNA-LNPs For Drug Discovery And Screening

Watch this short webinar to learn more about how to generate rapid, reproducible, and small-scale nanoparticle formulations to accelerate drug discovery and screening.